Norway· NO-ID_A5CD0A35-9B27-4FD0-B91B-073804B28D0A

Calciparina

A heparin product containing heparin calcium, registered in Norway by Italfarmaco S.p.A. The same ATC class is registered in 12 of our 19 countries.

ATC B01AB01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedCalciparinaATCB01AB01REGISTER NO.NO-ID_A5CD0A35-9B27-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Heparin is registered in 12 of 19 countries.

Countries holding a registration under ATC B01AB01 (heparin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Heparin · ATC B01AB01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Heparin Calcium
Manufacturer
Italfarmaco S.p.A
Country
Norway (NO)
ATC code
B01AB01
ATC class
Heparin
Defined daily dose
10 TSD, E
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_A5CD0A35-9B27-4FD0-B91B-073804B28D0A
  • no_varenummer
    216827
    10 x 0.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

714 interactions on record for heparin.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Heparin · interactions on record

714 records

  • 63 severe
  • 133 moderate
  • 18 minor
  • 500 info

Most severe, free to view

  • InotersenN07XX15severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B01AB01

Heparin, as other registers publish it.

All heparin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • France · Calciparine, Calciparine Sous Cutanee
  • United Kingdom (Northern Ireland) · Heparin Calcium Wockhardt Uk, Monoparin-Ca
  • Italy · Calciparina, Sosefluss

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1ac3aa67-21c7-4eb8-b048-f6386c4025aa
GET /v1/drugs/1ac3aa67-21c7-4eb8-b048-f6386c4025aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning i ferdigfylt sprøyte",
  "source": "fest",
  "status": "A",
  "atc_name": "Heparin",
  "merkevare_id": "ID_A5CD0A35-9B27-4FD0-B91B-073804B28D0A",
  "name_form_strength": "Calciparina inj, oppl 5000 IU/0,2 ml",
  "prescription_group": "C"
}

See everything about heparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.